Results Wire: US FDA Advisory Committee Discusses the Data Requirements for Food and Airborne Allergy Immunotherapies – JAN 21, 2016 (APAC)
On Thursday, January 21, 2016, the Allergenic Products Advisory Committee (APAC) discussed safety and effectiveness data, including challenge study endpoints, for licensure of food allergy immunotherapy products, and the clinical development of aeroallergen (airborne) immunotherapy products for the prevention of respiratory allergic disease.
See the SAC Tracker report